glp 1 approved for osa Tirzepatide in Obesity-Related Obstructive Sleep Apnea: Beyond Weight Loss Toward Disease Modification? Ozempic and sleep apnea: What

, Letchford, D

Hepatobiliary surgery and nutrition, 5(6), 515518

An estimated 50-75% of users stop taking these drugs within a year

Changes from baseline in hepatic analytes were assessed continuously and categorically, and screening for drug-induced liver injury/Hy's Law was conducted

Researching Quality of Weight Loss, Conditions Associated with Obesity and Long-term Health These efforts are increasing the versatility of our clinical programs for obesity and accelerating our mission to support an overall healthier life and quality, sustained weight lossas well as the associated long-term benefits

Method: Following the clinic, families (n=6) were invited to partake in semi-structured qualitative interviews that were audio-recorded, transcribed, and analyzed using thematic analysis